[{"id":"f677d36a-97eb-461c-8937-51246e927763","acronym":"","url":"https://clinicaltrials.gov/study/NCT05301010","created_at":"2022-03-29T12:53:28.718Z","updated_at":"2024-07-02T16:35:54.695Z","phase":"Phase 3","brief_title":"Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients","source_id_and_acronym":"NCT05301010","lead_sponsor":"Nanogen Pharmaceutical Biotechnology Joint Stock Company","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 overexpression • HER-2 amplification","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 overexpression • HER-2 amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Herceptin (trastuzumab) • docetaxel • Faceptor (trastuzumab biosimilar)"],"overall_status":"Completed","enrollment":" Enrollment 128","initiation":"Initiation: 02/02/2018","start_date":" 02/02/2018","primary_txt":" Primary completion: 02/19/2021","primary_completion_date":" 02/19/2021","study_txt":" Completion: 02/19/2021","study_completion_date":" 02/19/2021","last_update_posted":"2023-02-27"},{"id":"13eeb399-58eb-4f43-a479-428b5d23d9b6","acronym":"","url":"https://clinicaltrials.gov/study/NCT05301530","created_at":"2022-03-29T12:53:35.069Z","updated_at":"2024-07-02T16:36:14.496Z","phase":"Phase 1","brief_title":"Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.","source_id_and_acronym":"NCT05301530","lead_sponsor":"Nanogen Pharmaceutical Biotechnology Joint Stock Company","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 overexpression • HER-2 amplification","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 overexpression • HER-2 amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Herceptin (trastuzumab) • docetaxel • Faceptor (trastuzumab biosimilar)"],"overall_status":"Completed","enrollment":" Enrollment 50","initiation":"Initiation: 05/27/2019","start_date":" 05/27/2019","primary_txt":" Primary completion: 08/31/2020","primary_completion_date":" 08/31/2020","study_txt":" Completion: 02/19/2021","study_completion_date":" 02/19/2021","last_update_posted":"2022-03-29"}]